468 related articles for article (PubMed ID: 16304807)
1. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
2. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
Lally JA; Gnall EM; Seltzer J; Kowey PR
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
[TBL] [Abstract][Full Text] [Related]
3. Upstream effect for atrial fibrillation: still a dilemma?
Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
[TBL] [Abstract][Full Text] [Related]
4. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
5. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
6. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
Chávez LL
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
[TBL] [Abstract][Full Text] [Related]
7. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
McEwen DP; Martens JR
Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
Wettwer E; Christ T; Dobrev D; Ravens U
Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
[TBL] [Abstract][Full Text] [Related]
9. Non-antiarrhythmic drugs to prevent atrial fibrillation.
Moro C; Hernández-Madrid A; Matía R
Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for atrial fibrillation.
Mohammed KS; Kowey PR; Musco S
Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
13. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials, the renin angiotensin system and atrial fibrillation.
Birnie DH; Gollob M; Healey JS
Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
[TBL] [Abstract][Full Text] [Related]
16. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling).
Goette A; Bukowska A; Lendeckel U
Curr Opin Pharmacol; 2007 Apr; 7(2):219-24. PubMed ID: 17276728
[TBL] [Abstract][Full Text] [Related]
17. [New strategies in the treatment of atrial fibrillation].
Tamargo Menéndez J
An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
Davis EM; Packard KA; Hilleman DE
Pharmacotherapy; 2010 Jul; 30(7):749, 274e-318e. PubMed ID: 20575638
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacologic treatment of atrial fibrillation].
Lelakowski J
Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
[TBL] [Abstract][Full Text] [Related]
20. [Morphological remodeling in atrial fibrillation].
Goette A; Lendeckel U
Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]